Literature DB >> 27037389

HIV-indicator-condition-driven HIV testing: clinically effective but still rarely implemented.

Lauren Bull1, Michael Rayment2.   

Abstract

In the UK, outcomes for people living with HIV are excellent. However, a quarter of those living with HIV do not know their status, and almost half are diagnosed late. Strategies to broaden HIV testing are needed. HIV indicator conditions are those thought to be associated with HIV infection because they share risk factors (eg viral hepatitis) or because they arise as a result of early or late immunodeficiency (eg bacterial pneumonia, Kaposi's sarcoma). They comprise all AIDS-defining conditions, but also many non-AIDS-defining conditions spanning the spectrum of medicine. Patients presenting with indicator conditions should routinely be offered an HIV test. This approach is likely to be clinically effective, because knowledge of HIV status is essential in the management of many conditions. It is cost effective if the prevalence of HIV infection is greater than 0.1%. The strategy removes the need for risk assessment, and is acceptable to patients and healthcare practitioners. If broadly implemented, it is likely to be effective at a public health level, and will help to reduce both undiagnosed HIV and late diagnoses of HIV. Here we review the emerging evidence base that supports the value of routine HIV testing in indicator conditions.
© 2016 Royal College of Physicians.

Entities:  

Keywords:  HIV; HIV testing; indicator conditions; public health

Mesh:

Year:  2016        PMID: 27037389      PMCID: PMC4952973          DOI: 10.7861/clinmedicine.16-2-175

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  13 in total

1.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.

Authors:  Deborah Donnell; Jared M Baeten; James Kiarie; Katherine K Thomas; Wendy Stevens; Craig R Cohen; James McIntyre; Jairam R Lingappa; Connie Celum
Journal:  Lancet       Date:  2010-05-26       Impact factor: 79.321

2.  Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA.

Authors:  Gary Marks; Nicole Crepaz; Robert S Janssen
Journal:  AIDS       Date:  2006-06-26       Impact factor: 4.177

3.  HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy.

Authors:  Steven J Reynolds; Frederick Makumbi; Gertrude Nakigozi; Joseph Kagaayi; Ronald H Gray; Maria Wawer; Thomas C Quinn; David Serwadda
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

4.  Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Authors:  Gillian D Sanders; Ahmed M Bayoumi; Vandana Sundaram; S Pinar Bilir; Christopher P Neukermans; Chara E Rydzak; Lena R Douglass; Laura C Lazzeroni; Mark Holodniy; Douglas K Owens
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

5.  Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Authors:  A David Paltiel; Milton C Weinstein; April D Kimmel; George R Seage; Elena Losina; Hong Zhang; Kenneth A Freedberg; Rochelle P Walensky
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

6.  Assessing the predictive value of HIV indicator conditions in general practice: a case-control study using the THIN database.

Authors:  Sarah Damery; Linda Nichols; Roger Holder; Ronan Ryan; Sue Wilson; Sally Warmington; Helen Stokes-Lampard; Kaveh Manavi
Journal:  Br J Gen Pract       Date:  2013-06       Impact factor: 5.386

7.  HIV testing in non-traditional settings--the HINTS study: a multi-centre observational study of feasibility and acceptability.

Authors:  Michael Rayment; Alicia Thornton; Sundhiya Mandalia; Gillian Elam; Mark Atkins; Rachael Jones; Anthony Nardone; Patrick Roberts; Melinda Tenant-Flowers; Jane Anderson; Ann K Sullivan
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

Review 8.  Low levels of HIV test coverage in clinical settings in the U.K.: a systematic review of adherence to 2008 guidelines.

Authors:  Rahma Elmahdi; Sarah M Gerver; Gabriela Gomez Guillen; Sarah Fidler; Graham Cooke; Helen Ward
Journal:  Sex Transm Infect       Date:  2014-01-09       Impact factor: 3.519

Review 9.  Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?

Authors:  Myron S Cohen; M Kumi Smith; Kathryn E Muessig; Timothy B Hallett; Kimberly A Powers; Angela D Kashuba
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

10.  Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study).

Authors:  Ann K Sullivan; Dorthe Raben; Joanne Reekie; Michael Rayment; Amanda Mocroft; Stefan Esser; Agathe Leon; Josip Begovac; Kees Brinkman; Robert Zangerle; Anna Grzeszczuk; Anna Vassilenko; Vesna Hadziosmanovic; Maksym Krasnov; Anders Sönnerborg; Nathan Clumeck; José Gatell; Brian Gazzard; Antonella d'Arminio Monforte; Jürgen Rockstroh; Jens D Lundgren
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more
  2 in total

1.  Chronic diarrhoea.

Authors:  Joanne John; Mark D Lawton
Journal:  Clin Med (Lond)       Date:  2021-07       Impact factor: 2.659

2.  Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis.

Authors:  S J Bogers; S H Hulstein; M F Schim van der Loeff; G J de Bree; P Reiss; J E A M van Bergen; S E Geerlings
Journal:  EClinicalMedicine       Date:  2021-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.